Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Operating expenses:
Research and development	$ 343,789	$ 131,749	$ 1,109,050	$ 363,135
General and administrative	586,924	82,284	1,958,731	195,000
Total operating expenses	930,713	214,033	3,067,781	558,135
Loss from operations	(930,713)	(214,033)	(3,067,781)	(558,135)
Other expense:
Interest income			123
Interest expense	(60,413)		(88,641)
Total other expense	(60,413)		(88,518)
Net Loss	$ (991,126)	$ (214,033)	$ (3,156,299)	$ (558,135)
Basic and diluted net loss per share attributable to common stock	$ (0.01)	$ (0.04)	$ (0.06)	$ (0.09)
Basic and diluted weighted average common stock outstanding	74,526,579	6,068,762	52,131,543	6,043,904